title: Continuing inflammation does enhance spinally mediated antinociception by neostigmine in the rat model.
authors.forename: H
authors.initials: H
authors.lastname: Buerkle
authors.forename: C
authors.initials: C
authors.lastname: Bantel
authors.forename: R
authors.initials: R
authors.lastname: Wuesten
authors.forename: M
authors.initials: M
authors.lastname: Mae
authors.forename: H
authors.initials: H
authors.lastname: Van Aken
mesh_terms: D000109:Acetylcholine / Q000378:metabolism; D018712:Analgesics, Non-Narcotic / Q000494:pharmacology*; D000818:Animals; D004305:Dose-Response Relationship, Drug; D007249:Inflammation / Q000503:physiopathology*; D007278:Injections, Spinal; D008297:Male; D009388:Neostigmine / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013116:Spinal Cord / Q000187:drug effects* / Q000502:physiology
chemical_list: D018712:Analgesics, Non-Narcotic; D009388:Neostigmine; D000109:Acetylcholine